BIOLOGICAL-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF REQUIRES MEMBRANE TARGETING BY C-TERMINAL BASIC DOMAINS

被引:66
|
作者
GONCALVES, J
SHI, B
YANG, XY
GABUZDA, D
机构
[1] DANA FARBER CANC INST,DIV HUMAN RETROVIROL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115
关键词
D O I
10.1128/JVI.69.11.7196-7204.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) encodes a Vif protein which is important for virus replication and infectivity. Vif is a cytoplasmic protein which exists in both membrane-associated and soluble forms. The membrane-associated form is an extrinsic membrane protein which is tightly associated with the cytoplasmic side of membranes. We have analyzed the mechanism of membrane targeting of Vif and its role in HIV-1 replication, Mutagenesis studies demonstrate that C-terminal basic domains are required for membrane association. Vif mutations which disrupt membrane association also inhibit HIV-1 replication, indicating that membrane localization of Vif is likely to be required for its biological activity in vivo. Membrane binding of Vif is almost completely abolished by trypsin treatment of membranes, These results demonstrate that membrane localization of Vif requires C-terminal basic domains and interaction with a membrane-associated protein(s), This interaction may serve to direct Vif to a specific cellular site, since immunofluorescence staining and plasma membrane fractionation studies show that Vif is localized predominantly to an internal cytoplasmic compartment rather than to the plasma membrane, The mechanism of membrane targeting of Vif is different in some respects from that of other extrinsic membrane proteins, such as Ras, Src, and MARCKS, which utilize a basic domain together with a lipid modification for membrane targeting. Membrane targeting of Vif is likely to play an important role in HIV-1 replication and thus may be a therapeutic target.
引用
收藏
页码:7196 / 7204
页数:9
相关论文
共 50 条
  • [21] HEADACHE AND THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    HOLLOWAY, RG
    KIEBURTZ, KD
    HEADACHE, 1995, 35 (05): : 245 - 255
  • [23] STRUCTURE AND FUNCTION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PAVLAKIS, GN
    SEMINARS IN LIVER DISEASE, 1992, 12 (02) : 103 - 107
  • [24] RENAL COMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOURGOIGNIE, JJ
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1571 - 1584
  • [25] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CYTOMEGALOVIRUS IN SALIVA
    LUCHT, E
    ALBERT, J
    LINDE, A
    XU, WM
    BRYTTING, M
    LUNDEBERG, J
    UHLEN, M
    BRATT, G
    SANDSTROM, E
    HEIMDAHL, A
    NORD, CE
    WAHREN, B
    JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) : 156 - 162
  • [26] ANALYSIS OF LONG TERMINAL REPEAT CIRCLE JUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SMITH, JS
    KIM, SY
    ROTH, MJ
    JOURNAL OF VIROLOGY, 1990, 64 (12) : 6286 - 6290
  • [27] ANALYSIS OF NATURAL VARIATION IN THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GEELEN, JLMC
    KOKEN, SEC
    VANWAMEL, J
    BOUCHER, CAB
    GOUDSMIT, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 322 - 322
  • [28] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [29] CELL-DEPENDENT REQUIREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF PROTEIN FOR MATURATION OF VIRUS-PARTICLES
    SAKAI, H
    SHIBATA, R
    SAKURAGI, J
    SAKURAGI, S
    KAWAMURA, M
    ADACHI, A
    JOURNAL OF VIROLOGY, 1993, 67 (03) : 1663 - 1666
  • [30] ROLE OF THE BASIC DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MATRIX IN MACROPHAGE INFECTION
    FREED, EO
    ENGLUND, G
    MARTIN, MA
    JOURNAL OF VIROLOGY, 1995, 69 (06) : 3949 - 3954